Skip NavigationSkip to Content

Sulfiredoxin is an AP-1 target gene that is required for transformation and shows elevated expression in human skin malignancies

  1. Author:
    Wei, Q.
    Jiang, H.
    Matthews, C. P.
    Colburn, N. H.
  2. Author Address

    Wei, Qiou, Jiang, Hong, Matthews, Connie P.; Colburn, Nancy H.] Natl Canc Inst, Lab Canc Prevent, Ctr Canc Res, Frederick, MD 21701 USA.
    1. Year: 2008
  1. Journal: Proceedings of the National Academy of Sciences of the United States of America
    1. 105
    2. 50
    3. Pages: 19738-19743
  2. Type of Article: Article
  1. Abstract:

    Previous studies have shown that a dominant negative form of c-Jun (TAM67) suppresses mouse skin carcinogenesis both in vitro and in vivo. The current study identifies Sulfiredoxin (Srx) as a unique target of activator protein-1 (AP-1) activation and TAM67 inhibition. Manipulation of Srx levels by ShRNA or over-expression demonstrates that Srx is critical for redox homeostasis through reducing hyperoxidized peroxiredoxins. In JB6 cells, knockdown of Srx abolishes tumor promoter-induced transformation and enhances cell sensitivity to oxidative stress. Knockdown of Srx also impairs c-Jun phosphorylation, implicating a role for Srx in the feedback regulation of AP-1 activity. Screening of patient tissues by tissue microarray reveals elevated Srx expression in several types of human skin cancers. Our study indicates that Srx is a functionally significant target of AP-1 blockade that may have value in cancer prevention or treatment.

    See More

External Sources

  1. PMID: 19057013

Library Notes

  1. No notes added.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel